Table 1.
Rheumatoid arthritis (n = 469) |
Ankylosing spondylitis (n = 164) |
Peripheral psoriatic arthritis (n = 101) |
Axial psoriatic arthritis (n = 65) |
General population (n = 1579) |
|
Women (%) | 71.8 | 18.9 | 61.4 | 50.7 | 50.2 |
Age (years) | |||||
- mean (± SD) | 57.5 (14.3) | 51.7 (9.2) | 60.7 (11.6) | 58.2 (10.3) | 55.2 (19.2) |
Disease duration | |||||
- mean (± SD) | 6.1 (4.2) | 8.2 (4.6) | 7.5 (5.3) | 8.4 (4.3) | NA |
Educational level, n (%) | |||||
- primary school | 240 (51.2) | 70 (42.7) | 45 (44.6) | 30 (46.1) | 928 (58.8) |
- secondary school | 149 (31.8) | 65 (39.6) | 43 (42.6) | 25 (38.5) | 418 (26.5) |
- high school/university | 80 (17.0) | 29 (17.7) | 13 (12.8) | 10 (14.4) | 233 (14.7) |
No of comorbid conditions, n (%) | |||||
- none | 217 (46.3) | 73 (44.5) | 45 (44.6) | 19 (29.3) | 548 (34.7) |
- 1 | 131 (27.9) | 37 (22.6) | 26 (25.7) | 12 (18.5) | 334 (33.5) |
- 2 | 47 (10.0) | 30 (18.3) | 13 (12.9) | 21 (32.3) | 112 (7.1) |
- 3 | 20 (4.3) | 15 (9.1) | 15 (14.8) | 10 (15.4) | 69 (4.4) |
- 4 | 25 (5.3) | 6 (3.7) | 2 (2.0) | 2 (3.0) | 21 (1.3) |
- 5 or more | 29 (6.2) | 3 (1.8) | 0 (0) | 1 (1.5) | 12 (0.8) |
Comorbidity score by SCQ | 4.35 (3.1) | 2.48 (1.9) | 3.75 (2.5) | 3.34 (2.1) | 1.95 (1.9) |
- mean (± SD) | |||||
DAS | |||||
- mean (± SD) | 4.5 (0.8) | -- | 4.4 (0.9) | -- | NA |
BASDAI | -- | 54.7 (17.2) | -- | 53.8 (14.4) | NA |
- mean (± SD) | |||||
Rx Sharp score | 59.4 (32.9) | -- | 62.1 (39.1) | -- | NA |
- mean (± SD) | |||||
mSASSS | |||||
- mean (± SD) | -- | 14.7 (5.2) | -- | 13.7 (5.1) | NA |
PASI | |||||
- mean (± SD) | -- | -- | 7.1 (3.3) | 6.7 (2.9) | NA |
NA = non applicable
Abbreviations: DAS = Disease Activity Score; BASDAI = Bath Ankylosing Spondylitis Disease Activity index; mSASSS = modified Stoke Ankylosing Spondylitis Spine Score; PASI = Psoriasis Area and Severity Index